| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| KALA | KALA BIO, Inc. | Iwicki Mark T | CHIEF EXECUTIVE OFFICER | Jan 04, 2024 | Sale | $6.73 | 4,539 | 30,547 | 286,315 | Jan 05, 2024, 04:04 PM | |
| MRUS | Merus N.V. | Iwicki Mark T | Director | Apr 14, 2023 | Option Exercise | $7.27 | 73,576 | 534,679 | 73,576 | Apr 17, 2023, 08:26 AM | |
| KALA | Kala Pharmaceuticals, Inc. | Iwicki Mark T | CHIEF EXECUTIVE OFFICER | Jan 04, 2023 | Sale | $28.54 | 198 | 5,651 | 45,966 | Jan 06, 2023, 08:00 PM | |
| KALA | Kala Pharmaceuticals, Inc. | Iwicki Mark T | CHIEF EXECUTIVE OFFICER | Oct 26, 2022 | Sale | $6.52 | 561 | 3,658 | 4,464 | Oct 28, 2022, 04:15 PM | |
| KALA | Kala Pharmaceuticals, Inc. | Iwicki Mark T | CHIEF EXECUTIVE OFFICER | Jun 27, 2022 | Sale | $0.37 | 7,975 | 2,951 | 251,183 | Jun 29, 2022, 08:09 PM | |
| KALA | Kala Pharmaceuticals, Inc. | Iwicki Mark T | CHIEF EXECUTIVE OFFICER | Jan 04, 2022 | Sale | $1.30 | 9,518 | 12,373 | 259,158 | Jan 05, 2022, 08:00 PM | |
| KALA | Kala Pharmaceuticals, Inc. | Iwicki Mark T | CHIEF EXECUTIVE OFFICER | Oct 26, 2021 | Sale | $1.80 | 27,598 | 49,676 | 268,676 | Oct 28, 2021, 08:01 PM | |
| KALA | Kala Pharmaceuticals, Inc. | Iwicki Mark T | CHIEF EXECUTIVE OFFICER | Jun 28, 2021 | Sale | $5.77 | 7,586 | 43,771 | 296,274 | Jun 29, 2021, 05:25 PM | |
| AIMT | Aimmune Therapeutics, Inc. | Iwicki Mark T | Director | Oct 10, 2020 | Option Exercise | $34.50 | 39,567 | 1,365,062 | 0 | Oct 14, 2020, 04:15 PM | |
| AIMT | Aimmune Therapeutics, Inc. | Iwicki Mark T | Director | Oct 13, 2020 | Option Exercise | $34.50 | 7,840 | 270,480 | 0 | Oct 14, 2020, 04:15 PM | |
| AIMT | Aimmune Therapeutics, Inc. | Iwicki Mark T | Director | Feb 26, 2018 | Buy | $32.00 | 9,375 | 300,000 | 29,375 | Feb 26, 2018, 04:05 PM | |
| AIMT | Aimmune Therapeutics, Inc. | Iwicki Mark T | Director | Aug 11, 2015 | Buy | $16.00 | 20,000 | 320,000 | 20,000 | Aug 11, 2015, 11:40 AM |
Menu